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Abstract
An impaired amino acid sensing is associated with age-related loss of skeletal
muscle mass. We tested whether light-load resistance exercise (LL-RE) affects
postprandial amino acid transporter (AAT) expression in aging skeletal mus-
cle. Untrained, healthy men (age: +65 years) were subjected to 13 h of supine
rest. After 2 1/2 h of rest, unilateral LL-RE was conducted (leg extensions, 10
sets of 36 repetitions) at 16% 1RM. Thereafter, the subjects were randomized
into groups that orally ingested 40 g of whey protein either as hourly drinks
(4 g per drink) (PULSE, N = 10) or two boluses (28 g at 0 h and 12 g at
7 h) (BOLUS, N = 10), or hourly isocaloric maltodextrin drinks (placebo,
N = 10). Quadriceps muscle biopsies were taken at 0, 3, 7, and 10 h postexer-
cise from both the resting and exercised leg, from which the membrane pro-
tein and mRNA expression of select AATs were analyzed by Western Blot and
RT-PCR, respectively. LAT1 and PAT1 protein expression increased in
response to LL-RE in the PULSE group, and SNAT2 and PAT1 protein
expression increased in the BOLUS group when plasma BCAA concentration
was low. In all three groups, LL-RE increased LAT1 mRNA expression,
whereas a time course decrease in SNAT2 mRNA expression was observed.
LL-RE increased membrane-associated AAT protein expression and mRNA
expression. Altered AAT protein expression was only seen in groups that
ingested whey protein, with the greatest effect observed after hourly feeding.
This points toward an importance of AATs in the anabolic response following
LL-RE and protein intake.
Introduction
Feeding protein or free amino acids to adults is known to
stimulate muscle protein synthesis (MPS) (Bohe et al.
2001). The link between peripheral hyperaminoacidemia
and increased MPS results from cells sensing the increased
amino acid concentration, increased amino acid uptake,
and intracellular amino acid utilization for protein
translation (Bohe et al. 2003). The molecular link between
hyperaminoacidemia and increased MPS is the activation
of the mechanistic target of rapamycin complex 1
(mTORC1) signaling pathway (Fujita et al. 2007; Dreyer
et al. 2008; West et al. 2011; D’Souza et al. 2014). Activa-
tion of mTORC1 occurs when the complex anchors to
the lysosomal membrane (Bar-Peled and Sabatini 2014).
Among numerous upstream signals responsible for
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mTORC1 activation, three amino acid transporters
(AATs) are believed to play a central role: L-type amino
acid transporter 1 (LAT1)/solute-linked carrier (SLC)
7A5, sodium-coupled neutral amino acid transporter 2
(SNAT2)/SLC38A2, and proton-assisted amino acid trans-
porter 1 (PAT1)/SLC36A1 (Poncet and Taylor 2013). In
addition to being an important transporter of branched-
chain amino acids (BCAAs), especially leucine, LAT1 has
a catalytic subunit that is involved in nutrient signaling
and mTORC1 activation (Poncet et al. 2014). Further-
more, intracellular leucine is proposed to stimulate leucyl
tRNA synthetase (LRS) binding to the Rag-GTPase that is
involved in mTORC1 activation (Han et al. 2012).
SNAT2 transports glutamine into the cell, which is
needed for the exchange transport of BCAAs by LAT1.
Additionally, downstream SNAT2 signaling is believed to
be directly involved in mTORC1 activation (Pinilla et al.
2011), although the exact mechanism is unknown. PAT1
is important at the lysosomal membrane, where it is pro-
posed to be involved in vacuolar H(+)-ATPase (v-
ATPase) activity toward Ragulator, which together with
the Rag complex, is a central docking molecule for
mTORC1 at the surface of the lysosome (Zoncu et al.
2011; €Ogmundsdottir et al. 2012). It is unknown whether
AATs are rate limiting for mTORC1 activation, but intra-
cellular amino acid availability (Beugnet et al. 2003) and
especially the leucine concentration and repletion capacity
(Schriever et al. 2013) are related to mTORC1 signaling.
Aging increases skeletal muscle anabolic resistance, as
shown by a decreased (Cuthbertson et al. 2005) and
delayed (Drummond et al. 2008) response to anabolic
stimuli, such as resistance exercise and amino acid avail-
ability. The cellular change in advancing age that leads to
anabolic resistance is not yet fully understood. However,
decreased expression of AATs has been proposed (Drum-
mond et al. 2011), which would affect amino acid sensing
and subsequent signaling (Guillet et al. 2004; Cuthbertson
et al. 2005). Potent interventions to increase the expres-
sion of AATs could, therefore, imply a greater sensitivity
toward amino acids and, thus, attenuate anabolic resis-
tance. It has been shown that resistance exercise coupled
with amino acid ingestion increases AAT protein expres-
sion in young subjects (Drummond et al. 2011; Dickinson
et al. 2013) and AAT mRNA expression in young
(Churchward-Venne et al. 2012; Reidy et al. 2014) and
older subjects (Dickinson et al. 2014). Moreover, it has
been shown that increased amino acid availability alone
increases AAT protein (Drummond et al. 2010) and
mRNA expression (Drummond et al. 2010; Churchward-
Venne et al. 2012). Studies comparing the response to
resistance exercise and essential amino acid (EAA) intake
in young versus older subjects show different patterns in
AAT expression, which suggests that aging affects the
AAT response (Drummond et al. 2011; Dickinson et al.
2013).
Although most studies of skeletal muscle showed a
robust change in AAT mRNA expression in response to
anabolic stimuli (Churchward-Venne et al. 2012; Dickin-
son et al. 2014; Reidy et al. 2014), some studies showed
no, or very little, change in AAT protein expression
(Drummond et al. 2011; Reidy et al. 2014). Thus far,
studies of AAT protein expression in human skeletal mus-
cle have performed Western blotting on whole-muscle
homogenates. However, AATs incorporated into the
membrane through which they transport amino acids are
of the utmost importance. Posttranslational modification
and translocation of AATs have been suggested to occur
(Roos et al. 2009). Thus, fractionating muscle homoge-
nates and extracting the membrane fraction prior to Wes-
tern blotting would elucidate changes in AAT membrane
expression, thereby providing a clearer picture of changes
in the potential of amino acid sensing of the muscle cells.
Resistance exercise with a load equivalent to 70–80% of
the one-repetition maximum (1RM) is normally recom-
mended to induce muscle hypertrophy. However, recent
studies have shown hypertrophic and anabolic responses
even from resistance exercise at a light load (LL-RE) in
young (Holm et al. 2008; Burd et al. 2010; Bechshoeft
et al. 2013) and elderly subjects (Devries et al. 2015; Mur-
phy et al. 2015; Agergaard et al. 2017). Challenging the
hypertrophic response by resistance exercise at a low per-
centage of the 1RM is intriguing, as this could be a well
tolerable and applicable exercise for elderly and frail indi-
viduals to counteract age-related muscle atrophy. The
question is whether the anabolic response from LL-RE
could be ascribed to a greater skeletal muscle sensing of
nutrients.
Therefore, the purpose of the present study was to
investigate how resistance exercise with light loads and
protein intake provided via a frequent or bolus feeding
regimen alters the expression of membrane-associated
AATs. Moreover, AAT mRNA expression was measured
to elucidate the potential for de novo AAT synthesis. We
hypothesized that LL-RE would increase the protein and
mRNA expression of AATs, and that a greater effect
would be seen in groups receiving protein, albeit in a pat-
tern reflecting the feeding regime.
Materials and Methods
Ethical approval
Participants were informed about the study protocol, the
risks of tests and investigations, and their rights according
to the Declaration of Helsinki II before volunteering for
the project. The study protocol was approved by the
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Research Ethics Committee Region Hovedstaden Com-
mittee D (H-2-2012-041, 13 June 2012). All participants
gave written informed consent.
Subjects
Healthy elderly male subjects >65 years of age were
included through web and newspaper advertisement. Sub-
jects were excluded if they were smokers, had relatives
with type II diabetes, received daily medications or sup-
plements that could have an impact on muscle protein
synthesis, had an alcohol intake >21 units per week, had
a body mass index (BMI) >28, or regularly performed
exercise or did strenuous physical work. Randomization
of 30 subjects was double-blinded into one of three
groups; a control group that ingested an isocaloric carbo-
hydrate hourly (placebo) (N = 10), a protein group that
ingested protein hourly (the PULSE group) (N = 10), or
a protein group that ingested protein in two doses (the
BOLUS group) (N = 10). The groups were homogenous
in regard to age, height, weight, BMI, fat-free mass
(FFM), and 1RM muscle strength (Table 1). Data from
these subjects have recently been published (Agergaard
et al. 2017).
Inclusion
Body composition was measured by a dual X-ray absorp-
tiometry (DXA) scan, and blood samples were taken for a
general health screening at inclusion. Moreover, unilateral
quadriceps muscle strength was measured in a leg exten-
sion device (Technogym, Super Executive Line, Gambet-
tola, Italy) by a 3RM test from which the 1RM was
estimated using the Brzycki equation (Brzycki 1995). The
leg extensions were performed in a 90° range-of-motion
with a knee-joint angle from 100° to 10°. After a brief
warm-up on a Monarch cycle for 5 min, the subjects per-
formed three sets of five leg extensions at a light load
before the test in the leg extension device. During the test,
the subjects were instructed to perform four repetitions.
To avoid fatigue, the subjects were stopped after two rep-
etitions if they could easily perform the leg extensions,
and more weight was added. When they were able to per-
form only three, but not four, repetitions, the load was
noted as the 3RM.
Trial day
Prior to the trial day, the subjects were instructed not to
perform any strenuous physical exercise or work, ingest
sufficient protein, and refrain from alcohol- and caffeine-
containing substances for 1 week or 1 day, respectively,
before the trial day as previously described (Agergaard
et al. 2017). After overnight fasting, the subjects arrived
at the Institute of Sports Medicine Copenhagen, Bispe-
bjerg Hospital in the morning by taxi to avoid any physi-
cal activity.
After arrival, the subjects rested in the supine position,
and venous catheters were inserted retrograde into the
antecubital veins of both arms. At time point 45 min,
the LL-RE commenced (Fig. 1). The subjects performed
the exercise using the same device and at the same setting
as for the 3RM test. The exercise consisted of unilateral
leg extensions with 10 sets of 36 repetitions at 16% of
their 1RM. Subjects were randomized to exercise with
either their strongest or weakest leg. Each repetition lasted
5 sec: 2 sec in the concentric phase and 3 sec in the
eccentric phase, including a brief detensioning of the
exercising muscle before the next repetition. A break of
30 sec was given between each set. In total, the exercise
lasted for 35 min. The contralateral leg remained at rest.
The subjects returned to rest in the supine position
after the last exercise set. Thereafter, they were given the
first drink at time point 0 h (Fig. 1). In total, the PULSE
and BOLUS groups consumed equal amounts of protein
being 700 mg 9 kg FFM1 of whey protein isolate
(40.4 g on average) (LACPRODAN DI-9224, Arla Foods
Ingredients Group P/S, Denmark). The PULSE group
Table 1. Subject characteristics at baseline for the placebo, PULSE, and BOLUS groups. Data are shown as the mean  SD. Subject character-
istics have previously been published (Agergaard et al. 2017).
Placebo
N = 10
PULSE
N = 10
BOLUS
N = 10 P-value
Age (years) 73.0  4.7 71.6  4.3 69.7  4.7 0.28
Height (m) 1.78  0.06 1.75  0.07 1.77  0.06 0.55
Weight (kg) 80.7  6.8 79.8  11.8 79.5  9.5 0.96
BMI (kg m2) 25.4  1.5 26.0  3.0 25.2  1.9 0.71
FFM (kg) 59.1  5.9 57.6  4.7 57.8  4.7 0.76
1RM of Ex leg (kg) 44.6  10.8 43.0  6.1 42.7  6.7 0.86
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consumed whey protein drinks hourly (70 mg whey pro-
tein 9 kg FFM1, on average 4 g per drink) to keep an
elevated availability of AAs throughout the 10-h postexer-
cise period. The BOLUS group ingested the whey protein
in two boluses; the first drink containing 490 mg of whey
protein 9 kg FFM1, on average 28.3 g of whey protein,
at 0 h, and the second drink containing 210 mg of whey
protein 9 kg FFM1, on average 12.1 g of whey protein,
at 7 h. The PULSE group design is to a great degree aca-
demic. However, importantly the PULSE group was
included in the present study to make comparisons on
myofibrillar protein synthesis (MPS) presented in Ager-
gaard et al. (2017) with the study on young men by
Bechshoeft et al. (2013). In addition, the BOLUS group
was designed with a more realistic approach toward
protein feeding. The protein provision in the BOLUS
group was skewed (28 g at 0 h and 12 g at 7 h) in
order to match the amount of protein ingested in the
PULSE group within the same time period (28 g in
total from 0–7 h and 12 g in total from 7–10 h). The
placebo group consumed 665 mg 9 kg FFM1 (isocalo-
ric) maltodextrin, approximately 38 g in total (Glucidex
IT19, Roquette, Clement Lise, France), which was given
in the same hourly feeding pattern as that of the
PULSE group (Fig. 1). Beside these drinks, the subjects
were only allowed to consume water throughout the
study period.
Muscle biopsies
At 0, 3, 7, and 10 h, muscle biopsies were taken from
each leg. The muscle biopsies were obtained from the lat-
eral part of the vastus lateralis muscle with a 4-mm
biopsy needle (Bergstr€om, Stockholm, Sweden). Briefly,
the skin was shaved and disinfected before local anestheti-
zation (1% lidocaine). Immediately before biopsy sam-
pling, the placebo or protein drink was administered. An
incision was made through which a muscle biopsy was
taken. Thereafter, the incision was strapped with Stea-
Strips and covered with waterproof plaster. Subsequently,
the thigh muscle was compressed for 30 min with an elas-
tic band and a compression pad at the incision site to
avoid an intramuscular hematoma. A new incision was
made for each biopsy, with approximately 3 cm between
each incision. The incisions were made in a randomized
order between subjects, but in the same order for the
exercised and resting leg within subjects. When taken, the
muscle specimen was quickly freed from any visible
blood, fat, and connective tissue, frozen in liquid N2 and
stored at 80°C until further analysis.
Amino acid concentrations
Plasma amino acid (AA) concentrations were measured
from blood samples taken at baseline immediately after
exercise (0 h) and at 0.5, 1, 2, 3, 5, 7, 7.5, 8, 9, and 10 h
into the postprandial period. Liquid chromatography tan-
dem mass-spectrometry (LC-MS/MS) (TSQ Vantage;
Thermo Fisher Scientific, San Jose, CA) was used to mea-
sure the amino acid concentrations as described elsewhere
(Bornø and van Hall 2014). For the analysis, 150 lL of
plasma was used. Importantly, each of the individual 19
amino acids was quantified using its own stable
isotopically labeled internal standard (uniformly labe-
led-13C/15N). Because of the substantial cost of the LC-
MS/MS analysis, the number of time points was reduced
in the three groups, but in a fashion that matched the
time points where changes would be expected. Thus, in
the placebo group, amino acid concentrations were mea-
sured at 0, 0.5, 1, 2, 6, and 10 h, while those of the
PULSE group was measured at 0, 0.5, 1, 2, 4, 6, 8, and
10 h, and those of the BOLUS group were measured at 0,
0.5, 1, 2, 3, 5, 7, 7.5, 8, 9, and 10 h. A flood-primed
(1320 mg unlabeled phenylalanine and 165 mg of
Figure 1. Study design of the 13-h trial period. X denotes blood sampling, B denotes muscle biopsy sampling and cylinders denote time and
the amount of placebo or protein intake in the three groups.
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ring-13C6-phenylalanine, Cambridge Isotopes Laboratories,
Andover, MA) continuous infusion (ring-13C6-phenylala-
nine 8.0 lmol 9 kg FFM1 9 h1) of a phenylalanine
tracer was applied to measure the fractional synthetic rate,
which is presented elsewhere (Agergaard et al. 2017).
Thus, phenylalanine was withdrawn from the calculations
of EAAs and total AAs so that the AA data would solely
reflect the different feeding regimens.
Muscle tissue fractionation
Skeletal muscle tissue samples were fractionated into mem-
brane and cytosolic fractions. Approximately 30 mg of fro-
zen skeletal muscle tissue per sample was homogenized.
The muscle specimen was placed into a cooled glass tube
(Pyrex glass tube, Corning, NY) and homogenization buf-
fer was added (10 lL mg1 tissue). The homogenization
buffer consisted of 25 mmol L1 Tris-HCl, 0.5 mmol L1
EGTA, 2 mmol L1 EDTA, 1 mmol L1 PMSF,
1 mmol L1 DTT, and 300 mmol L1 sucrose, pH 7.2.
Immediately before using the homogenization buffer, a
1:100 dilution of a phosphatase inhibitor cocktail (Cal-
biochem, no. 524624, Merck Millipore, Billerica, MA),
20 lmol L1 leupeptin and 120 lmol L1 pepstatin A was
added. The sample was homogenized with a glass pestle
(Pyrex glass pestle tissue grinder, Corning) mounted on a
tabletop homogenizer (Eurostar Power Basic, IKA Works
Inc., Wilmington, NC), transferred to a separate tube and
centrifuged at 1000g for 15 min at 4°C. Subsequently, the
supernatant containing cytosolic proteins was transferred
to a cooled ultracentrifuge tube (Beckman Coulter Inc.,
no. 343778, Brea, CA) and used for other analyses. To the
pellet containing the membrane fraction, homogenization
buffer (160 lL) containing 1% IGEPAL 680 was added.
The pellet was resuspended by vortex and transferred to a
cooled ultracentrifuge tube and incubated for 30 min. Sub-
sequently, the sample was centrifuged at 100,000g for
30 min at 4°C. After centrifugation, the supernatant was
transferred to new Eppendorf tubes for further analysis,
and the protein concentration was quantified with a Brad-
ford-based microplate protein assay (#500-0006, Bio-Rad,
Hercules, CA); the protein yield was 4.75  0.97 lg mg1
(mean  SD) of wet-weight muscle tissue. The purity of
the fractions was validated by blotting for Caveolin-1
(membrane protein), Insulin Receptor b (membrane pro-
tein), and GAPDH (cytosolic protein) on both membrane
and cytosolic fraction (data not shown).
Western blotting
Western blotting was performed on the membrane fraction
to measure the expression of the AATs. Membrane fraction
samples were diluted 1:1 in 29 sample buffer
(1.25 mol L1 Tris pH 6.8, 25% v/v glycerol, 2.5% SDS,
2.5% v/v b-mercaptoethanol and 0.2% w/v bromophenol
blue). Samples were heated at 95°C for 3 min prior to
loading on SDS-PAGE gels. Five micrograms of protein
was loaded per well on 26-well 15% Criterion Tris-HCl
precast gels (Bio-Rad) and resolved by SDS-PAGE for 1 h
at 150 V in electrophoresis buffer (25 mmol L1 Tris-
Base, 190 mmol L1 glycine and 3.5 mmol L1 SDS). Pro-
teins were blotted by wet transfer (#170-3912, Bio-Rad) to
PVDF membranes (Bio-Rad) for 1 h at 50 V in transfer
buffer (10 mmol L1 CAPS pH 11.0 and 10% v/v metha-
nol). Membranes were blocked for 45 min at room tem-
perature with 2% skimmed milk powder in Tris-buffered
saline (TBS) containing Tween-20 (TBST). The mem-
branes were incubated with primary antibodies overnight
at 4°C in a solution of 2% skimmed milk powder in TBST.
The primary antibodies were LAT1 (ab85226; Abcam,
Cambridge, MA) diluted 1:1000, SNAT2 (sc-67081; Santa
Cruz Biotechnology, Dallas, TX) diluted 1:2000, and PAT1
(ab110513; Abcam) diluted 1:500. The next morning, the
membranes were washed in TBST and secondary anti-rab-
bit antibody (sc-2313, Santa Cruz Biotechnology) diluted
1:6000 in 2% skimmed milk powder in TBST was added to
the membranes and incubated for 1 h at room tempera-
ture. Subsequently, the membranes were washed in TBST,
incubated with chemiluminescence reagent (ECL Plus, GE
Healthcare, Pittsburgh, PA) for 5 min, and visualized on a
chemiluminescence imager (ChemiDoc XRS+, Bio-Rad).
Band intensities were quantified using ImageJ (National
Institutes of Health, Bethesda, MD).
Ponceau-S staining of the membranes was used to con-
trol that equal amounts of protein had been loaded onto
the gels before SDS-PAGE by evaluating the Ponceau-S
staining of a selected band of interest from the samples of
each subject. Membranes were stained with a Ponceau-S
solution for 5 min at room temperature and washed twice
for 5 min in dH2O. Images of the membranes were
obtained (ChemiDoc XRS+, Bio-Rad) and band intensities
were quantified using ImageJ (National Institutes of
Health). Instead a membrane-specific housekeeping pro-
tein could have been used as loading control. However,
since the current study includes both exercise and nutri-
tional interventions, applying a membrane-specific protein
as housekeeping protein could fail to be reliable, as the
expression must be stable regardless of the intervention but
also regardless of time (not affected by diurnal fluctuation).
Thus, Ponceau-S staining was applied in the current study.
RT-PCR
Reverse transcription-PCR was used to measure the
mRNA expression of LAT1, SNAT2, and PAT1. RNA was
purified with TriReagent (RT 118; Molecular Research
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Center, Cincinnati, OH) from approximately 10 mg of
muscle tissue as previously described (Agergaard et al.
2015). cDNA synthesis was performed using Omniscript
reverse transcriptase (Qiagen, Hilden, Germany), using
250 ng of muscle RNA and amplified with specific pri-
mers (0.1 lmol L1 each, Table 2) as previously
described (Agergaard et al. 2015).
The housekeeping genes glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) and ribosomal protein large P0
(RPLP0) served as controls. When normalizing the level
of GAPDH to that of RPLP0, an overall decrease in
GAPDH expression was observed in the exercised leg
compared with the resting leg in the PULSE group
(P = 0.048) (Fig. 2B), and a tendency toward a difference
in the expression of GAPDH and RPLP0 between legs
was seen in the ANOVA testing in the placebo
(P = 0.063) and BOLUS groups (P = 0.084) (Fig. 2A and
C). We do not believe that the scale of the quick decrease
in GAPDH expression normalized to RPLP0 that seemed
to appear at 0 h in response to exercise in the PULSE
group was due to an immediate synthesis of RPLP0, but
rather due to degradation of GAPDH mRNA. Therefore,
we expect changes in GAPDH mRNA expression, normal-
ized to that of RPLP0, to be caused by changes in
GAPDH mRNA expression; thus, RPLP0 was chosen as
the housekeeping gene, and all mRNA expression data
were normalized to RPLP0 expression.
Statistics
The normality of data was assessed by Shapiro–Wilk nor-
mality test. However, due to a low sample size (N), these
normality tests would sometimes fail. In that case,
histogram was plotted to visually assess normality and
skewness.
Subject characteristics were analyzed by one-way
ANOVA using Prism 6 (GraphPad Software, La Jolla, CA).
Plasma AA concentrations were log-transformed before
being subjected to ANOVA analysis, as they would other-
wise not be normally distributed. One-way ANOVA test-
ing was performed within groups with a post hoc test
(Dunnett’s test) to reveal changes from the baseline.
Because the measured plasma AA concentrations for the
placebo and PULSE groups seemed to be linearly
expressed after 1 h, a linear regression analysis was per-
formed using Prism 6 (GraphPad Software) on the levels
measured from 1 to 10 h to reveal whether the plasma
AA levels changed over time.
Two-way ANOVA with repeated measures for time
were conducted on plasma leucine and BCAA concentra-
tions for time points common to all three groups. When-
ever two-way ANOVA testing showed significant
differences (P < 0.05), post hoc tests (the Bonferroni pro-
cedure) were performed.
The area under the curve (AUC) for plasma leucine
and BCAA were calculated from the available time points.
If blood could have been drawn every half hour, multiple
peaks in the plasma leucine and BCAA concentrations
would have been revealed in the PULSE group after each
drink. Thus, the total AUC for the PULSE group was
underestimated. Plasma leucine and BCAA AUCs were
analyzed by one-way ANOVA with a post hoc test (Stu-
dent–Newman–Keuls test) whenever ANOVA testing
showed significant differences (P < 0.05).
Amino acid transporter protein and mRNA expression
were subjected to two-way ANOVA with repeated mea-
sures for leg and time within group to analyze the effect
of LL-RE. Whenever ANOVA testing showed significant
differences (P < 0.05), a post hoc test (Student–Newman–
Keuls test) was performed.
Unless otherwise stated, Sigma Plot version 12.0 (Systat
Software Inc., San Jose, CA) was used for the statistical
analysis. All plasma AA data are shown as the
mean  SEM. Before ANOVA testing, protein and
mRNA expression were log-transformed, due to the loga-
rithmic nature of the data after normalized to the resting
leg at 0 h. Protein and mRNA data are shown as the geo-
metric mean (GeoMean)  back-transformed SEM. A
P < 0.05 was considered to be statistically significant.
Results
Amino acid concentrations
All measurements of plasma concentrations for each indi-
vidual BCAA (leucine, valine, and isoleucine) during the
Table 2. Primers for RT-PCR analyses of housekeeping genes and AA
Target Sense primer Antisense primer Ref. sequence
RPLP0 GGAAACTCTGCATTCTCGCTTCCT CCAGGACTCGTTTGTACCCGTTG NM_053275.3
GAPDH CCTCCTGCACCACCAACTGCTT GAGGGGCCATCCACAGTCTTCT NM_002046.4
LAT1 GTGGCTCCTCCAGGGCATCT CTCGGCCTCCTGGCTATGTCTC NM_003486.5
SNAT2 AAACACCACCTTAACACAGCCAACA TGAAAAGATCAGAATTGGCACAGCA NM_018976.4
PAT1 ACCCCAGCCACCTCCCCTTG GAACTTCCGAGGATCCTTCATTTTG NM_078483.2
2017 | Vol. 5 | Iss. 18 | e13444
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10-h postprandial period were higher than those at the
baseline (0 h) (P < 0.05) for the PULSE and BOLUS
groups (Table 3). Linear regression on measurements
made from 1 h onwards showed that the plasma concen-
trations in the PULSE group increased over time for leu-
cine (R2 = 0.6039, P < 0.0001), valine (R2 = 0.4382,
P < 0.0001), and isoleucine (R2 = 0.6112, P < 0.0001)
(Table 3).
Plasma leucine and BCAA concentrations were higher
in the PULSE and BOLUS groups than in the placebo
group at 0.5, 1, 2, and 10 h (for all the time points,
P < 0.001 for both the PULSE and BOLUS groups)
(Fig. 3A and B). Leucine and BCAA levels measured at
0.5, 1, and 2 h were higher (all P < 0.001) in the BOLUS
group than in the PULSE group, but when measured at
10 h, the PULSE group had higher concentrations of leu-
cine (P < 0.001) and BCAA (P = 0.002) than the BOLUS
group. Thus, as seen in Figure 3A and B, the group with
the highest circulating leucine and BCAA levels shifted
during the 10-h postprandial period. Although the AUCs
for the PULSE group were underestimated since blood
could not be drawn every half hour, a higher AUC for
the leucine concentration was observed in the PULSE
(P < 0.001) and BOLUS (P < 0.001) groups compared
with that of the placebo group, and higher AUCs for the
BCAA concentration were observed in the PULSE
(P < 0.001) and BOLUS (P < 0.001) groups compared
with that of the placebo group (Fig. 3C and D). However,
the AUC for leucine (P = 0.104) and BCAA (P = 0.091)
did not significantly differ between the PULSE and
BOLUS groups.
AAT membrane protein expression
Representative blots from Western blot analyses of the
select AATs are shown in Figure 4. In the PULSE group,
LAT1 expression was higher in the exercised leg com-
pared with the resting leg during the postexercise period
(P = 0.011), but no time point-specific differences were
observed (Fig. 5B). At 3 h, the expression was higher
compared with that at 0 h (P = 0.007), but with no leg-
specific differences observed. In the placebo and BOLUS
groups, LAT1 expression did not display significant differ-
ences (Fig. 5A and C).
Sodium-coupled neutral amino acid transporter 2
(SNAT2) expression increased at 3 h compared with that
at 0 h in the PULSE group (P = 0.018) (Fig. 5E), but with
no significant leg differences observed. In the BOLUS
group, higher SNAT2 expression was seen in the resting
leg than in the exercised leg throughout the postexercise
period (P = 0.013) (Fig. 5F), and SNAT2 expression was
greater at 7 h than at 0 h (P = 0.028), but with no leg-
specific differences. Significant differences in SNAT2
expression were not seen in the placebo group (Fig. 5D).
In the PULSE group, PAT1 expression was greater in
the exercised leg than in the resting leg at 3 h (P = 0.012)
(Fig. 5H). For the BOLUS group, PAT1 expression was
greater in the exercised than in the resting leg (P = 0.049)
throughout the whole postexercise period (Fig. 5I), and it
was greater at 7 h (P = 0.009) and 10 h (P = 0.012) than
at 0 h, but with no leg-specific differences. No differences
in PAT1 expression were seen in the placebo group
(Fig. 5G).
AAT mRNA expression
Light-load resistance exercise increased LAT1 mRNA
expression, which was observed as an overall difference
between the resting and exercised legs, in the placebo
(P = 0.020), PULSE (P = 0.002) and BOLUS (P = 0.004)
groups (Fig. 6A, B and C). At 3 h in the placebo group,
LAT1 mRNA expression was higher compared with that
at 0 (P = 0.004), 7 (P = 0.026) and 10 h (P = 0.001), but
it was not significantly related to the exercised leg. In the
PULSE and BOLUS groups, only a tendency toward an
interaction effect from ANOVA testing was seen
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(P = 0.062 and P = 0.083, respectively); thus, no post hoc
test could be performed to reveal time point-specific
differences.
Sodium-coupled neutral amino acid transporter 2
(SNAT2) mRNA expression in the placebo group
decreased at 7 (P = 0.006) and 10 h (P < 0.001) com-
pared with that at 0 h, and at 7 (P = 0.024) and 10 h
(P = 0.003) compared with that at 3 h; no leg-specific
differences were observed (Fig. 6D). In the PULSE group,
SNAT2 mRNA expression decreased at 10 h compared
with that at 0 (P = 0.037) and 3 h (P = 0.045), and no
leg-specific differences were observed (Fig. 6E). In the
BOLUS group, SNAT2 mRNA expression decreased in
the exercised leg at 7 (P = 0.001) and 10 h (P = 0.018)
compared with that at 0 h, and at 7 (P = 0.002) and 10 h
(P = 0.018) compared with that at 3 h (Fig. 6F).
In the placebo group, PAT1 mRNA expression
increased from 3 to 7 h (P = 0.024), and no leg-specific
differences were observed (Fig. 6G). No significant
changes in PAT1 mRNA expression were observed in
either the PULSE or BOLUS groups (Fig. 6H and I).
Discussion
The main purpose of the present study was to investigate
the impact of LL-RE, with or without protein intake, on
the expression of membrane-associated AATs. We
demonstrated that LL-RE, combined with whey protein
intake, increases the membrane-associated protein expres-
sion of select AATs. To our knowledge, we are the first to
fractionate human muscle homogenates to study exercise
and nutrient effects on AAT expression. Whey protein
intake primarily resulted in a robust change in plasma
BCAA concentrations reflecting the intake pattern, indi-
cating that these amino acids, combined with exercise,
could be driving the regulation of AAT protein expres-
sion. Moreover, LL-RE increased LAT1 mRNA expression
irrespective of the feeding regimen, whereas SNAT2
mRNA expression decreased over time in all three groups,
although only in the exercised leg of the BOLUS group.
Because acute changes in the expression of membrane-
associated AATs are very much related to AAT function
(Hyde et al. 2001; Hundal and Taylor 2009), we fraction-
ated homogenized skeletal muscle tissue in this study.
This allowed us to only observe changes in the expression
of membrane-associated AATs, which provides insight
into changes in the potential for amino acid transport
and sensing, whereas previous studies have looked at
changes in AAT protein expression in whole-muscle tissue
homogenates (Drummond et al. 2010, 2011; Dickinson
et al. 2013). However, we should acknowledge that these
previous studies have reported the regulation of AATs in
young and old subjects in response to RE with (Dickinson
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et al. 2013) or without (Drummond et al. 2011) a postex-
ercise EAA drink. Dickinson et al. (2013) only saw up-
regulated LAT1 protein expression in old subjects,
whereas only young subjects displayed an increase in
SNAT2 protein expression. Drummond et al. (2011) only
saw up-regulated LAT1 protein expression in young sub-
jects. Thus, both studies indicate that aging affects the
AAT response. Despite differences in study design, the
increased expression of membrane-associated LAT1, in
response to exercise and frequent protein intake in elderly
subjects in the present study (Fig. 5B), is in line with
previous findings that showed an increase in LAT1
expression in a whole-muscle homogenate in response to
heavy-load RE and EAA intake (Dickinson et al. 2013).
An increase in membrane-bound LAT1 could facilitate a
greater capacity for influx of leucine, which is important
for mTORC1 activation. Moreover, Dickinson et al.
(2013) did not observe any change in whole-muscle cell
SNAT2 protein expression in elderly subjects, which is in
line with the membrane-associated SNAT2 protein
expression in the present study, where only a time course
effect was seen in the PULSE (Fig. 5E) and BOLUS
groups (Fig. 5F). Moreover, we showed that PAT1 mem-
brane-associated protein expression increased in response
to LL-RE with PULSE or BOLUS protein intake. Such an
increase in lysosomal membrane-bound PAT1 would
increase the capacity for mTORC1 docking and subse-
quent activation at the lysosomal membrane.
The membrane-associated AAT expression response to
LL-RE and protein ingestion seems to be affected by the
protein ingestion regimen, frequent or bolus. Direct
comparisons of groups, legs, and time with a three-way
ANOVA have not been made, as the sample size was
too small to perform a reliable test. Thus, group com-
parisons were evaluated qualitatively, discussing the
changes seen within each group individually. The clearest
distinction between groups was seen in LAT1 protein
expression, where an overall increase in expression was
seen in the exercised leg compared with that of the rest-
ing leg in the PULSE group, whereas neither exercise-
induced nor time-dependent changes were seen in the
BOLUS group. The distinct LAT1 protein expression
between the PULSE and BOLUS groups could be a mat-
ter of supply and demand. Most likely, the intracellular
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Figure 3. Plasma concentrations of (A) leucine and (B) BCAA measured in postabsorptive state at 0 h and continuously for 10 h in the
postprandial phase at the denoted time points. The dotted line represents the phase where peaks in leucine and BCAA levels, as seen at 0.5 h,
are expected to occur. The AUC for (C) leucine and (D) BCAA concentrations were calculated from the available time points. *Different from
the placebo group. #Different from the PULSE group. Data are shown as the mean  SEM
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AA pool was depleted more rapidly in the PULSE group
than in the BOLUS group in the first 3 h of the post-
prandial phase because of lower plasma AA concentra-
tions (Table 3), caused by a different total amount of
protein consumed until this time point; PULSE 12 g
and BOLUS 28 g of whey protein. Thus, the early (3 h)
increased LAT1 and also SNAT2 protein expression in
the PULSE group could increase the potential for reple-
tion of intracellular BCAAs, thus, matching the demand.
Unfortunately, due to a lack of muscle tissue for intra-
cellular AA measurement, we do not have data on intra-
cellular AA concentrations. For the BOLUS group, a
Figure 4. Representative blots from the Western blot analysis of membrane-associated LAT1, SNAT2, and PAT1 protein expression, and
Ponceau-S staining of the evaluated protein band. Blots are shown for one subject loaded in replicates from each individual group (placebo,
PULSE, and BOLUS) for the resting and exercised leg at 0, 3, 7, and 10 h. The observed size of the protein bands is indicated for each
individual protein target.
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substantial increase in the plasma AA concentration was
seen after the first protein bolus (Table 3). The very
quick increase in circulating amino acids and the con-
comitant increase in insulin (Agergaard et al. 2017) after
ingesting the whey proteins were presumably sensed
immediately by the peripheral muscle cells, which could
facilitate a dose-dependent increase in the amino acid
flux into the muscle cells (Biolo et al. 1995, 1997). Thus,
the supply of AA in the BOLUS group could be suffi-
cient without the need for increasing membrane-asso-
ciated LAT1 protein expression to match the
intracellular need for AA in the initial 3-h period.
Instead, SNAT2 and PAT1 protein expression increased
at 7 h in the BOLUS group. This increased AAT expres-
sion could be caused by low plasma AA concentrations
in the BOLUS group at this point (Fig. 3 and Table 3),
to match a possible lower supply of AAs.
One important limitation of the membrane fractiona-
tion technique of the muscle homogenates is that it does
not distinguish between different membranes (e.g.,
plasma, nuclear, or lysosomal membranes). Thus, we can-
not definitely state the site at which the membrane-asso-
ciated AAT expression changed. We only showed that the
capacity for AA transport of the muscle cells changed,
and along with that suggest that the changes in the
expression of membrane-associated LAT1 and SNAT2
would occur at the plasma membrane, while that of
PAT1 would occur at the lysosomal membrane, where
these AATs have been shown to have an important effect
on mTORC1 activation (Poncet and Taylor 2013). Future
laboratory approaches, for example, microscope tech-
niques, could potentially illustrate specific AAT transloca-
tions and site-specific AAT expression in response to
interventions such as exercise and protein intake.
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Reverse transcription-PCR was performed to analyze
AAT mRNA expression. This would elucidate the poten-
tial for de novo AAT synthesis, while the expression of
membrane-associated proteins showed the immediate
capacity for amino acid flux. The expression of LAT1
mRNA increased in response to LL-RE, irrespective of the
feeding regimen. This indicates the importance of LAT1
in the anabolic response to resistance exercise, although
over the course of 10 h we only saw this translated into
increased membrane-associated protein expression in the
PULSE group. SNAT2 mRNA expression decreased over
time in all three groups, and in the BOLUS group, this
effect was significant only for the exercised leg. We do
not believe that this effect can be caused by the increased
AA availability, as decreased SNAT2 mRNA expression
was also observed in the placebo group; nor can it solely
be ascribed to a circadian effect, as in the BOLUS group
the decrease was merely seen in the exercised leg. Notably,
we observed similar mTORC1 signaling effects, especially
for eukaryotic elongation factor 2 (eEF2) (Agergaard et al.
2017), but, a connection require further research.
Decreased SNAT2 transporter activity would decrease
intracellular glutamine transport, which will inhibit the
capacity for intracellular BCAA uptake, thus tapering AA-
driven mTORC1 activation (Nicklin et al. 2009). The
increased LAT1 mRNA expression is in line with previous
findings on the responses to heavy-load RE in the elderly
(Drummond et al. 2011; Dickinson et al. 2013). In con-
trast, the present study is the first to show a decrease in
SNAT2 mRNA expression from the baseline to late into
the postexercise period. The studies by Drummond et al.
(2011) and Dickinson et al. (2013) showed an increase in
SNAT2 mRNA expression 3 h into the postheavy-load
exercise period, which returned to basal levels at 6 h. The
increased SNAT2 mRNA expression at 3 h could be an
effect of the heavy-load RE in those studies compared
with the lack of an effect at 3 h in response to LL-RE in
the present study. The need to maintain greater hypertro-
phy signaling in response to heavy-load RE could be the
significant difference compared with the present study.
For the two whey protein groups (PULSE and BOLUS),
the exact same amount of protein (700 mg whey protein
9 kg FFM1, or approximately 40 g of whey protein in
total) was ingested throughout the 10-h postexercise per-
iod. Although underestimated for the PULSE group, we
also observed the same AUC for the leucine and BCAA
concentrations for the PULSE and BOLUS groups. The
PULSE strategy was chosen to maintain an elevated avail-
ability of AAs for a prolonged period of time and,
thereby, to copy the previous study design of Bechshoeft
et al. (2013), whereas the strategy with two boluses was
chosen as a more applicable approach toward protein
intake, while still equalizing the total amount of protein
ingested throughout the study. Because of the different
protein ingestion patterns (PULSE vs. BOLUS) (Fig. 1),
differences in plasma AA concentrations were seen;
BOLUS feeding causing two spikes in plasma AA concen-
trations, whereas PULSE feeding resulting in a small but
prolonged increase in plasma AA concentrations
(Table 3). Thus, the different responses between the
PULSE and BOLUS groups were not caused by different
whey protein amounts in the total 10-h postprandial per-
iod, but by the different feeding regimens causing differ-
ent plasma AA concentrations.
The cause of age-related deterioration of skeletal mus-
cle mass (Janssen et al. 2000) is believed to be multifacto-
rial (Morley et al. 2011), but several studies have
documented anabolic effects of resistance exercise and
amino acid administration (either in the form of whole
protein, BCAAs, or EAAs) in elderly subjects (Kosek et al.
2006; Dideriksen et al. 2011; Symons et al. 2011; Yang
et al. 2012), thus proposing a way to diminish the aging
process of skeletal muscle. The effects of resistance train-
ing and hyperaminoacidemia result in a positive muscle
protein net balance, which is mainly caused by an
increase in MPS. Elsewhere, we have shown that LL-RE in
elderly subjects results in greater MPS throughout the 10-
h postexercise period, irrespective of placebo or protein
(PULSE or BOLUS) intake (Agergaard et al. 2017). Nota-
bly, we only saw a small effect of protein intake. How-
ever, as shown in the present study, LL-RE, together with
protein intake, seemed to potentiate anabolic mechanisms
that make skeletal muscle more susceptible to AAs. This
effect was especially evidenced by increased LAT1 protein
expression throughout the entire 10-h postexercise period
in the PULSE group, which increased the capacity for leu-
cine uptake. An adequate supply of AAs for protein syn-
thesis is known to be important for the anabolic response
(Biolo et al. 1997, 1999). Therefore, we believe that the
ability of an exercise regimen to increase the expression
of AATs is important, as it makes the skeletal muscle
more susceptible to AA availability and, thus, may make
the muscle more anabolic potent. Previously, it has been
shown that in the absence of previous exercise, elderly
subjects responded less to a given amount of EAAs
(Cuthbertson et al. 2005). However, resistance exercise
prior to protein or EAA intake has been shown to induce
the same increase in MPS in young and elderly subjects
(Drummond et al. 2008; Pennings et al. 2011). Therefore,
resistance exercise, which induces an increase in AAT
protein expression, could shift the leucine threshold
(Breen and Phillips 2011), thereby causing a greater ana-
bolic response to protein ingestion. However, long-term
studies are needed to elucidate whether resistance training
with a light load increases the basal expression of AATs
and whether this translates into a greater AA sensing
ª 2017 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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and, thereby, counteracts anabolic resistance to protein
ingestion.
Conclusion
Light-load RE followed by whey protein intake increased
the expression of membrane-associated LAT1 and PAT1
in elderly subjects. Different feeding regimens, PULSE or
BOLUS, which induced different levels and patterns of,
especially, plasma BCAA concentrations, affected the
expression of AATs, as increased LAT1 protein expression
was only seen following LL-RE and PULSE feeding,
whereas SNAT2 and PAT1 protein expression increased
in the BOLUS group in a period with a low plasma
BCAA concentration. This suggests that plasma BCAA
concentrations could affect membrane-associated AAT
expression. LL-RE induced an increase in LAT1 mRNA
expression, suggesting the importance of LAT1 in the
anabolic response to resistance exercise. In contrast,
SNAT2 mRNA expression decreased over time. The effect
of LL-RE on AAT protein and mRNA expression points
toward an anabolic effect of LL-RE, although future stud-
ies must clarify how the present acute response will trans-
late into long-term changes.
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